↓ Skip to main content

The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action

Overview of attention for article published in BMC Cancer, March 2012
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
65 Mendeley
Title
The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action
Published in
BMC Cancer, March 2012
DOI 10.1186/1471-2407-12-92
Pubmed ID
Authors

Laurie Hamtiaux, Julien Masquelier, Giulio G Muccioli, Caroline Bouzin, Olivier Feron, Bernard Gallez, Didier M Lambert

Abstract

The incidence of melanoma is considerably increasing worldwide. Frequent failing of classical treatments led to development of novel therapeutic strategies aiming at managing advanced forms of this skin cancer. Additionally, the implication of the endocannabinoid system in malignancy is actively investigated.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
United Kingdom 1 2%
Unknown 62 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 23%
Student > Bachelor 8 12%
Student > Ph. D. Student 6 9%
Other 5 8%
Student > Master 4 6%
Other 11 17%
Unknown 16 25%
Readers by discipline Count As %
Medicine and Dentistry 14 22%
Agricultural and Biological Sciences 8 12%
Biochemistry, Genetics and Molecular Biology 5 8%
Chemistry 4 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 7 11%
Unknown 24 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2015.
All research outputs
#20,189,002
of 22,705,019 outputs
Outputs from BMC Cancer
#6,483
of 8,258 outputs
Outputs of similar age
#144,516
of 159,707 outputs
Outputs of similar age from BMC Cancer
#49
of 59 outputs
Altmetric has tracked 22,705,019 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,258 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 159,707 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.